 SAFETY AND EFFICACY EXTENSION STUDY OF DACLIZUMAB HIGH YIELD PROCESS DAC HYP IN PARTICIPANTS WITH MULTIPLE SCLEROSIS WHO HAVE COMPLETED STUDY 205MS201 NCT00390221 TO TREAT RELAPSING-REMITTING MULTIPLE SCLEROSIS: 